Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

172 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prospective observational study to explore genes and proteins predicting efficacy and safety of brigatinib for ALK-gene rearranged non-small-cell lung cancer: study protocol for ABRAID study (WJOG11919L).
Ozawa Y, Koh Y, Hase T, Chibana K, Kaira K, Okishio K, Ichihara E, Murakami S, Shimokawa M, Yamamoto N. Ozawa Y, et al. Among authors: ichihara e. Ther Adv Med Oncol. 2024 Jan 27;16:17588359231225046. doi: 10.1177/17588359231225046. eCollection 2024. Ther Adv Med Oncol. 2024. PMID: 38282663 Free PMC article.
A definite case of (L)-carbocisteine-induced pneumonia with CATCH22 syndrome.
Kudo K, Ichihara E, Hisamoto A, Hotta K, Miyahara N, Tanimoto Y, Akagi S, Kato K, Tanimoto M, Kiura K. Kudo K, et al. Among authors: ichihara e. Intern Med. 2013;52(1):97-100. doi: 10.2169/internalmedicine.52.7882. Epub 2013 Jan 1. Intern Med. 2013. PMID: 23291681 Free article.
Early palliative care in non-small-cell lung cancer.
Ichihara E, Matsuoka J, Kiura K. Ichihara E, et al. N Engl J Med. 2010 Dec 2;363(23):2263; author reply 2264-5. doi: 10.1056/NEJMc1010529. N Engl J Med. 2010. PMID: 21121847 No abstract available.
Treatment Rationale and Design for J-SONIC: A Randomized Study of Carboplatin Plus Nab-paclitaxel With or Without Nintedanib for Advanced Non-Small-cell Lung Cancer With Idiopathic Pulmonary Fibrosis.
Otsubo K, Kishimoto J, Kenmotsu H, Minegishi Y, Ichihara E, Shiraki A, Kato T, Atagi S, Horinouchi H, Ando M, Kondoh Y, Kusumoto M, Ichikado K, Yamamoto N, Nakanishi Y, Okamoto I. Otsubo K, et al. Among authors: ichihara e. Clin Lung Cancer. 2018 Jan;19(1):e5-e9. doi: 10.1016/j.cllc.2017.06.003. Epub 2017 Jun 20. Clin Lung Cancer. 2018. PMID: 28687482
Nintedanib plus chemotherapy for nonsmall cell lung cancer with idiopathic pulmonary fibrosis: a randomised phase 3 trial.
Otsubo K, Kishimoto J, Ando M, Kenmotsu H, Minegishi Y, Horinouchi H, Kato T, Ichihara E, Kondo M, Atagi S, Tamiya M, Ikeda S, Harada T, Takemoto S, Hayashi H, Nakatomi K, Kimura Y, Kondoh Y, Kusumoto M, Ichikado K, Yamamoto N, Nakagawa K, Nakanishi Y, Okamoto I. Otsubo K, et al. Among authors: ichihara e. Eur Respir J. 2022 Dec 15;60(6):2200380. doi: 10.1183/13993003.00380-2022. Print 2022 Dec. Eur Respir J. 2022. PMID: 35361630 Free article. Clinical Trial.
Efficacy of gilteritinib in comparison with alectinib for the treatment of ALK-rearranged non-small cell lung cancer.
Ando C, Ichihara E, Nishi T, Morita A, Hara N, Takada K, Nakasuka T, Watanabe H, Kano H, Nishii K, Makimoto G, Kondo T, Ninomiya K, Fujii M, Kubo T, Ohashi K, Matsuoka KI, Hotta K, Tabata M, Maeda Y, Kiura K. Ando C, et al. Among authors: ichihara e. Cancer Sci. 2023 Nov;114(11):4343-4354. doi: 10.1111/cas.15958. Epub 2023 Sep 15. Cancer Sci. 2023. PMID: 37715310 Free PMC article.
172 results